	US 11,986,485 B1
	Compositions and methods for treating epilepsy
John Docherty, Port Perry (CA); and Christopher Andrew Bunka, Kelowna (CA)
Assigned to POVIVA CORP, Carson City, NV (US)
Filed by POVIVA CORP, Carson City, NV (US)
Filed on Jul. 24, 2023, as Appl. No. 18/225,234.
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/00 (2006.01); A61K 47/28 (2006.01); A61K 47/36 (2006.01); A61K 47/44 (2017.01); A61P 25/08 (2006.01)

CPC A61K 31/658 (2023.05) [A61K 47/28 (2013.01); A61K 47/36 (2013.01); A61K 47/44 (2013.01); A61P 25/08 (2018.01)]

22 Claims

1. A composition, consisting of:

a) from about 5 mg to about 32 mg by weight of a Cannabis sativa extract (CBD oil) containing from about 88% to about 91% by weight of cannabidiol;

b) from about 10 mg to about 65 mg by weight of sunflower oil;

c) from about 75 mg to about 300 mg by weight of bile salts containing from about 45% to about 55% by weight of cholic acid, deoxycholic acid, taurocholate; glycocholic acid, and mixtures thereof;

d) from about 35 mg to about 150 mg by weight of sodium bicarbonate; and

e) from about 110 mg to about 465 mg of gum Arabic.